GLGLENVIEW CAPITAL MANAGEMENT, LLC

Institutional investor · Portfolio as of Q3 2025

SEC EDGAR SourceSEC Filings

Top Holdings54 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction

CVS HEALTH CORPORATION

8.2M$618M13.8%$57.60+26.86%
8 qtrssince 2023-Q4
Unchanged
0

TENET HEALTHCARE CORP

2.3M$471.8M10.5%$55.91+259.89%
28 qtrssince 2018-Q4
Decreased
0

GLOBAL PAYMENTS INC

5.1M$427.2M9.5%$114.40-24.76%
20 qtrssince 2020-Q4
Increased
72
SPYSPY
PUT

STATE STREET SPDR S&P 500 ETF TRUST CL USD INC

566,700$377.5M8.4%
New
TEVATEVA
ADR

TEVA PHARMACEUTICAL-SP ADR

16.7M$337.2M7.5%$14.78+29.79%
8 qtrssince 2023-Q4
Increased
64

ZOOMINFO TECHNOLOGIES INC

18.5M$201.9M4.5%$10.64+9.12%
6 qtrssince 2024-Q2
Increased
63

AMAZON.COM INC

652,138$143.2M3.2%$176.79+25.67%
11 qtrssince 2023-Q1
Increased
64

THERMO FISHER SCIENTIFIC INC

282,941$137.2M3.1%$442.58+4.32%
2 qtrssince 2025-Q2
Increased
89

DXC TECHNOLOGY CO

8.3M$113.7M2.5%$25.92-47.42%
28 qtrssince 2018-Q4
Increased
69

UNIVERSAL HEALTH SERVICES-B

482,169$98.6M2.2%$162.37+4.71%
12 qtrssince 2022-Q4
Increased
62

PAYPAL HOLDINGS INC

1.3M$89.4M2.0%$66.11-8.53%
3 qtrssince 2025-Q1
Increased
60

VIATRIS INC

8.2M$81.7M1.8%$10.37-8.30%
8 qtrssince 2023-Q4
Unchanged
0

US FOODS HOLDING CORP

1.1M$81.6M1.8%$44.14+73.88%
16 qtrssince 2021-Q4
Decreased
0

DICKS SPORTING GOODS INC

351,601$78.1M1.7%$203.76+7.31%
2 qtrssince 2025-Q2
Increased
56

EXPEDIA GROUP INC

359,793$76.9M1.7%$119.61+84.04%
13 qtrssince 2022-Q3
Decreased
0

ZILLOW GROUP INC - C

889,666$68.5M1.5%$80.540.00%
1 qtr
New
68

ALIGHT INC

20.4M$66.4M1.5%$7.54+78.15%
13 qtrssince 2022-Q3
Decreased
0

ICON PLC

371,418$65M1.4%$163.44+3.68%
1 qtr
New
67

MARVELL TECHNOLOGY INC

676,980$56.9M1.3%$74.48+214.61%
3 qtrssince 2025-Q1
Increased
68

UNITED AIRLINES HOLDINGS INC

582,009$56.2M1.3%$74.68+32.08%
3 qtrssince 2025-Q1
Increased
47
$4.5B
AUM
54
Positions
Q3 2025
Filing
Rating · 3.5
Quarterly Portfolio Change
-11%Q2'24$5.1B+2%Q3'24$5.2B-23%Q4'24$4B+3%Q1'25$4.1B-12%Q2'25$3.6B+26%Q3'25$4.5B
Activity profile
$ moved · Q3'25
New42%Increased31%Decreased18%Exited9%
Composition
Equity vs derivatives
Equity92%Puts8%Calls0%
Holding period
Avg 3.0 years
<1Q20%1-4Q15%1-2Y7%2Y+57%

GLENVIEW CAPITAL MANAGEMENT, LLC manages $4.5B across 54 positions as of Q3 2025. Top holdings: CVS (13.8%), THC (10.5%), GPN (9.5%). Fund DNA: Balanced Allocator. HoldingsIntel Rating: 3.5/5.0.

Q3 2025 Summary

Active quarter - 17 new positions, 6 exits, 19 increased. Top move: TMO (INCREASED, conviction 89). Portfolio: $4.5B across 54 positions.

Top holdings by portfolio weight

Total AUM$4B
CVS13.76%
THC10.50%
GPN9.51%
TEVA7.51%
GTM4.49%
AMZN3.19%
TMO3.05%
DXC2.53%
UHS2.19%
PYPL1.99%
Other1.82%

Portfolio allocation by GICS sector

Sectors9
Healthcare54.10%
Technology14.44%
Industrials12.70%
Consumer Cyclical9.67%
Communication Services2.50%
Financial Services2.17%
Consumer Defensive1.98%
Basic Materials1.59%
Unknown0.84%

Behavioral investing profile

Checking access…
Balanced Allocator- primarily Healthcare, Technology, Industrials
Compare DNA across all funds
7-dimension quality assessment
Strong(3.5 / 5.0)
Track Record72
Conviction49
Concentration88
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
5Q
GPNGPNGLOBAL PAYMENTS INC
Q2 2025 Q2 2026+5.1M shares+$274.8M
4Q
AMZNAMZNAMAZON.COM INC
Q3 2025 Q2 2026+708,813 shares+$179.6M
4Q
EYEEYENATIONAL VISION HLDGS INC
Q3 2025 Q2 2026+2.3M shares+$40.3M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used